Metraipolis › archive › dc_9dfcb328900e

Risk of Heart Failure Hospitalization Associated With Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors Versus Erythropoiesis-Stimulating Agents: A… — Europe PMC PMID:42666150

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42666150
DOI
10.1002/pds.70453
License (as archived)
solo-consultazione
Archived
2026-10-07T20:36:33.812Z
SHA-256 of the archived text
d6a7def0a158fdba517772005f894f2627beca588d65d54da1534db3950056f1
Stable URL of this page
https://metraipolis.com/documento/dc_9dfcb328900e

How to cite

Risk of Heart Failure Hospitalization Associated With Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors Versus Erythropoiesis-Stimulating Agents: A… — Europe PMC PMID:42666150 — Europe PMC (en), https://europepmc.org/article/MED/42666150 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9dfcb328900e (Metraipolis archive dc_9dfcb328900e, sha256 d6a7def0a158fdba517772005f894f2627beca588d65d54da1534db3950056f1)
BibTeX
@misc{dc9dfcb328900e,
  title = {Risk of Heart Failure Hospitalization Associated With Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors Versus Erythropoiesis-Stimulating Agents: A… — Europe PMC PMID:42666150},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42666150},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9dfcb328900e; sha256 d6a7def0a158fdba517772005f894f2627beca588d65d54da1534db3950056f1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42666150. Agents can read the archived copy with the MCP tool read_document.